SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000932471-18-003616
Filing Date
2018-02-09
Accepted
2018-02-09 09:52:19
Documents
1

Document Format Files

Seq Description Document Type Size
1 junotherapeuticsinc.htm SC 13G/A 43903
  Complete submission text file 0000932471-18-003616.txt   45405
Mailing Address PO BOX 2600 V26 VALLEY FORGE PA 19482-2600
Business Address PO BOX 2600 V26 VALLEY FORGE PA 19482-2600 6106691000
VANGUARD GROUP INC (Filed by) CIK: 0000102909 (see all company filings)

IRS No.: 231945930 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 400 DEXTER AVENUE NORTH, SUITE 1200 SEATTLE WA 98109
Business Address 400 DEXTER AVENUE NORTH, SUITE 1200 SEATTLE WA 98109 2065821600
Juno Therapeutics, Inc. (Subject) CIK: 0001594864 (see all company filings)

IRS No.: 463656275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88476 | Film No.: 18588995
SIC: 2836 Biological Products, (No Diagnostic Substances)